Coronavirus (COVID-19) Update: Get the latest information on how we’re responding to the novel coronavirus (COVID-19). CLICK HERE »
Dr. Gunderson is passionate about medical oncology and the treatment of all forms of cancer, with a special interest in breast cancer. She partners with her patients to determine the best treatment options for their cancer. Dr. Gunderson believes in providing compassionate care, and treats her patients as she would want a loved one to be treated.
In her free time, Dr. Gunderson enjoys cooking, gardening and spending time with her family.
A Phase 3, Open-label, Randomized Study of Datopotamab Deruxtecan (Dato-DXd) Versus Investigator’s Choice of Chemotherapy in Patients who are not Candidates for PD-1/PD-L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast02).
View DetailsPhase 3 Study of Pembrolizumab with Concurrent Chemoradiation Followed by Pembrolizumab with or without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC).
View Details
